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ABSTRACT
This study describes the genetic relationships and
antimicrobial resistance determinants found
among 99 clinical isolates of enterococci from 15
different hospitals in Cuba. Pulsed-field gel elec-
trophoresis SmaI analysis demonstrated a high
degree of genetic diversity. A limited number of
multiresistant Enterococcus faecalis clones, showing
resistance to three or more families of antimicro-
bial agents, were detected simultaneously in
different institutions, suggesting inter-hospital
circulation of selected clones, and ⁄ or selection of
particular clones following their introduction into
the hospital environment. Antimicrobial resist-
ance determinants, including erm(B), aac(6¢)–
aph(2¢), aph(3¢), ant(6), vanB (E. faecalis) and vanA
(Enterococcus faecium) were detected by PCR in
various isolates.
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The genus Enterococcus includes different species
that behave either as commensal bacteria or as
causative agents of nosocomial infections [1].
Although enterococci are resistant intrinsically
to several antimicrobial agents, they can also
acquire and combine different mechanisms of
resistance to most active compounds. The epi-
demiology of nosocomial infections caused by
enterococci in various countries has been reported
extensively [1–3], although most studies focus
only on vancomycin-resistant isolates. The anti-
microbial susceptibilities of enterococci isolated
from Cuban hospitals have been reported recently
[4]. The aims of the present study were to
characterise the genetic determinants responsible
for the resistance observed and to establish the
genetic relatedness between the isolates.
In total, 99 consecutive isolates (83 Enterococcus
faecalis, 11 Enterococcus faecium, two Enterococcus
casseliflavus, two Enterococcus gallinarum and one
Enterococcus durans ⁄ hirae), recovered between
October 2000 and September 2001 from 15 differ-
ent Cuban hospitals (in the provinces of Las
Tunas, Santiago de Cuba and Habana City) and
various clinical specimens (33 urine samples, 19
blood samples, nine surgical wounds, seven
catheter tips, five abscesses, four cerebrospinal
fluids, four vaginal fluids, four endotracheal
secretions, four urethral swabs, three ear swabs,
and seven other sources) were studied. Only one
isolate per patient was included. Species identifi-
cation was performed with the WIDER Automatic
System (Francisco Soria Melguizo SA, Madrid,
Spain).
b-Lactamase production was determined in all
ampicillin-resistant isolates using nitrocefin (Ox-
oid, Basingstoke, UK). The presence of resistance
genes was investigated by PCR using specific
primers and conditions described previously
(vanA, vanB [5], erm(B), erm(A), erm(C), mef(A)
[6], aac(6¢)–aph(2¢), aph(3¢), ant(6), ant(3¢), aph(2¢)-id
and aph(2¢)-ic [7–10]) (Table 1). Control strains
used in PCR experiments were: E. faecalis Dela-
ware for aac(6¢)–aph(2¢¢) [10]; E. casseliflavus
SF11300 for aph(2¢¢)-Id [10]; E. gallinarum SF911
for aph(2¢¢)-Ic [10]; E. faecium RC714 for vanA
aph(3¢)-IIIa and erm(B) [11]; Staphylococcus aureus
RN1389 for erm(A) [12]; S. aureus RN4220 for
erm(C) [12]; and Streptococcus pyogenes 02C1064 for
mef(A) [12]. All PCRs included positive and
negative controls.
Chromosomal DNA was prepared as described
previously [13] and digested with SmaI. Elec-
trophoresis was carried out in a CHEF DR-II
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apparatus (Bio-Rad, La Jolla, CA, USA) using
pulse times of 5–35 s for E. faecalis and 2–28 s for
other species. Pulsed-field gel electrophoresis
(PFGE) profiles were analysed with Phoretrix
v.5.0 software, applying the Dice coefficient [14],
and were interpreted according to the criteria
proposed by Tenover et al. [15] (i.e., closely
related if ‡ 80% similarity; possibly related if
‡ 70% similarity).
The results are summarised in Table 2. Overall,
high diversity was observed among the entero-
coccal PFGE patterns, with 49 different patterns
identified among the 83 E. faecalis isolates. Nine
different patterns were identified among the ten
E. faecium isolates, the two isolates of E. casse-
liflavus were identical, and the two E. gallinarum
isolates had different patterns. Multiresistance
(resistance to three or more different families of
antimicrobial agents) was detected in 27 (55%)
E. faecalis clones, five (55%) E. faecium clones, and
one (50%) E. casseliflavus clone. E. faecalis clones
with the highest incidence of multiresistance
were: clone I (six isolates, tetracycline- or tetra-
cycline- and ciprofloxacin-resistant); clone C (five
isolates, either fully susceptible or tetracycline-
resistant); and clones D and A (five isolates each,
four resistant to aminoglycosides, chlorampheni-
col and tetracycline, and the other concomitantly
resistant to erythromycin and ciprofloxacin).
Other patterns observed consisted of clones with
three isolates each: clone E (all resistant to
tetracycline, and two resistant to streptomycin
and ciprofloxacin); clone H (two susceptible
isolates and one resistant to ciprofloxacin); and
clone Q (all resistant to aminoglycosides, chlo-
ramphenicol and tetracycline, and one resistant to
ciprofloxacin).
Four major clones were identified among the
E. faecalis isolates (clones I, C, D and A), with
clones A and D being multiresistant. Moreover,
clone C (hospitals 2, 3 and 4), clone A (hospitals 1
and 7) and clone D (hospitals 4 and 6) were
present simultaneously in different institutions.
Another 13 PFGE patterns, represented by two
isolates each, were observed. Most of the isolates
were recovered from Havana City, mainly from
hospital 4, although isolates with PFGE patterns
C, D, F and H were recovered from other
hospitals in this city. Clones A, C and L were
found in hospitals from geographically distant
regions. Clone G comprised two identical isolates,
although only one carried the vanB gene.
Five of nine E. faecium isolates (belonging to
four different clones) and one E. casseliflavus
isolate were resistant to ampicillin, although none
produced b-lactamase. Among these isolates, five
were also resistant to other antimicrobial agents
(Table 2) and one E. faecium isolate had the vanA
genotype. Among the isolates (40 E. faecalis, three
E. faecium and one E. casseliflavus) that showed
erythromycin resistance, the erm(B) gene was
detected in 32 (72.7%) cases; the remaining 12
also failed to amplify with specific primers for
erm(A), erm(C) and mef(A).
The glycopeptide resistance rate was low (2%),
probably because of rational use of vancomycin
and the absence of any concomitant pressure
exerted by teicoplanin (this antibiotic is not avail-
able in Cuba). Moreover, avoparcin has never been
used as a growth promoter for animals in Cuba.
One isolate each of E. faecalis and E. faecium were
detected that were resistant to vancomycin
because of a vanB and a vanA gene, respectively.
The gene for the so-called aminoglycoside-
inactivating bifunctional enzyme was present in
all isolates with high-level resistance (HLR) to
gentamicin. The aph(2¢)-Ic and aph(2¢)-Id genes
were not found, although a previous study
reported these genes in 10% of isolates with
gentamicin HLR [16]. Similarly, amikacin HLR
was mediated by the presence of the aac(6¢)–aph
(2¢¢) gene (14 isolates) or the aph(3¢) gene (two
isolates), or by the presence of both genes (21
isolates), as described previously [17–19]. The
Table 1. Primers used for detection of antimicrobial resist-
ance genes
Genes Primer sequence (5¢ ﬁ 3¢) Reference
vanA CAT GAA TAG AAT AAA AGT TGC AAT A [5]
CCC CTT TAA CGC TAA TAC GAT CAA
vanB GTG ACA AAC CGG AGG CGA GGA [5]
CCG CCA TCC TCC TGC AAA AAA
erm(B) GAA AAG RTA CTC AAC CAA AAT A [6]
AGT AAC GGT ACT TAA ATT GTT TAC
erm(A) TCT AAA AAG CAT GTA AAA GAA [6]
CTT CGA TAG TTT ATT AAT ATT AGT
erm(C) TCA AAA CAT AAT ATA GAT AAA [6]
GCT AAT ATT GTT TAA ATC GTC AAT
mef(A) AGT ATC ATT AAT CAC TAG TGC [6]
TTC TTC TGG TAC TAA AAG TGG
aac(6¢)–aph(2¢) CCA AGA GCA ATA AGG GCA TA [7]
CAC TAT CAT AAC CAC TAC CG
aph(3)-IIIA GCC GAT GTG GAT TGC GAA AA [7]
GCT TGA TCC CCA GTA AGT CA
ant(6) ACT GGC TTA ATC AAT TTG GG [8]
GCC TTT CCG CCA CCT CAC CG
ant(3¢) TGA TTT GCT GGT TAC GGT GAC [9]
CGC TAT GTT CTC TTG CTT TTG
aph(2¢)-Ic CCA CAA TGA TAA TGA CTC AGT TCC C [10]
CCA CAG CTT CCG ATA GCA AGA G
aph(2¢)-Id GTG GTT TTT ACA GGA ATG CCA TC [10]
CCC TCT TCA TAC CAA TCC ATA TAA CC
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Table 2. Characteristics of the 99 enterococcal isolates recovered from 15 different Cuban hospitals
Isolate Region Hospital Origin (no.) Clone No. Antibiotic resistance phenotype Genes detected by PCR
Enterococcus Las Tunas 8 Abscess L 1 Sm, Gen, Amk, Chlo, Ery, Tet aac(6¢)–aph(2¢), aph(3¢), ant(6), ant(3¢), erm(B)
faecalis Santiago de Cuba 1 Urine A 1 Sm, Gen, Amk, Chlo, Ery, Tet aac(6¢)–aph(2¢), aph(3¢), ant(6), erm(B)
1 Catheter ⁄Wound A ⁄A¢ 2 Sm, Gen, Amk, Chlo, Ery, Tet aac(6¢)–aph(2¢), aph(3¢), ant(6), erm(B)
2 Urine B 1 Chlo, Ery, Tet erm(B)
2 Wound B 1 Gen, Ery, Chlo, Tet, Cip aac(6¢)–aph(2¢), erm(B)
2 Exudate (2) ⁄Catheter C 3
3 Exudate C 1 Tet
3 Catheter AV 1 Tet
2 Catheter AU 1
2 Catheter AW 1 Sm, Tet
Havana City 7 Endotracheal tube A¢ 1 Gen, Amk, Tet, Chlo, Cip aac(6¢)–aph(2¢)
4 Urine C¢ 1
6 Blood D 1 Tet
4 Urine D 1 Sm, Gen, Amk, Chlo, Tet aac(6¢)–aph(2¢), aph(3¢)
4 Endotracheal tube D 1 Gen, Amk, Chlo, Ery, Tet aac(6¢)–aph(2¢), erm(B)
4 Gastric catheter D 1 Gen, Amk, Chlo, Ery, Tet, Cip aac(6¢)–aph(2¢), erm(B)
4 Blood D 1 Gen, Amk, Chlo, Ery, Tet aac(6¢)–aph(2¢), aph(3¢), erm(B)
5 Exudate E¢ 1 Cip
6 Blood E¢ 2 Sm, Tet, Cip
5 Blood F 1 Tet
4 Urine F¢ 1 Sm, Gen, Amk, Chlo, Ery, Tet, Cip aac(6¢)–aph(2¢), aph(3¢), ant(6), erm(B)
4 Urine G 1 Tet
4 Urine G¢ 1 Gen, Amk, Van aac(6¢)–aph(2¢), vanB
4 Urine H 2
12 Myringotomy H¢ 1 Cip
4 Blood I 2 Tet, Cip
4 CSF ⁄TCH ⁄Urine (2) I¢ 4 Tet
4 Blood J 2 Tet, Cip
4 Wound ⁄Urine K 2 Sm, Gen, Amk, Chlo, Ery, Tet aac(6¢)–aph(2¢), aph(3¢), ant(6), erm(B)
4 Urine L¢ 1 Sm, Gen, Amk, Chlo, Ery, Tet aac(6¢)–aph(2¢), aph(3¢), ant(6), erm(B)
4 Blood M 1 Ery, Tet erm(B)
4 Blood M 1 Gen, Amk, Chlo, Ery, Tet aac(6¢)–aph(2¢), erm(B)
4 Blood ⁄Urine N 2 Gen, Amk, Chlo, Ery, Tet, Cip aac(6¢)–aph(2¢), erm(B)
5 Blood ⁄Urine O 2 Gen, Amk, Chlo, Ery aac(6¢)–aph(2¢), erm(B)
5 Blood P 1 Tet, Cip
5 Blood P¢ 1 Tet
7 Vulva Q 1 Sm, Amk, Gen, Chlo, Ery, Tet aac(6¢)–aph(2¢), aph(3¢), ant(6), erm(B)
7 Urethra Q¢ 1 Amk, Gen, Chlo, Ery, Tet, Cip aac(6¢)–aph(2¢), aph(3¢), ant(6), erm(B)
7 Catheter Q¢ 1 Sm, Amk, Gen, Chlo, Ery, Tet aac(6¢)–aph(2¢), aph(3¢), ant(6)
9 Sputum R 1 Tet, Cip
10 Vaginal S 1 Cip
10 Vaginal T 1 Ery, Cip
9 Sputum U 1
11 Sputum V 1 Sm, Ery, Tet, Cip
4 Urine W 1 Ery, Tet, Cip
13 Wound X 1 Chlo, Tet, Cip
4 Urine Y 1 Gen, Amk, Chlo, Ery, Tet aac(6¢)–aph(2¢), erm(B)
4 Urine Z 1 Gen, Ery, Tet aac(6¢)–aph(2¢), erm(B)
4 Urine AA ⁄AA¢ 2 Chlo, Tet
14 Abscess AB 1 Chlo, Ery, Tet erm(B)
4 Urine AC ⁄AC¢ 2 Sm, Gen, Amk, Chlo, Ery, Tet aac(6¢)–aph(2¢), aph(3¢), ant(6), erm(B)
4 Wound AD 1 Tet
4 Urine AE 1 Tet
4 Urine AF 1 Tet
4 Umbilical cord AG 1 Sm, Gen, Amk, Chlo, Ery, Tet aac(6¢)–aph(2¢), aph(3¢), ant(6), ant(3¢), erm(B)
4 Urine AH 1 Sm, Amk, Ery, Cip aph(3¢), ant(6), ant(3¢), erm(B)
4 Urine AI 1 Ery, Tet, Cip erm(B)
4 Urine AJ 1 Tet
4 Urine AK 1 Tet
4 Urine AL 1 Chlo, Ery, Tet
4 Urine AM 1 Sm, Gen, Amk, Chlo, Ery, Tet aac(6¢)–aph(2¢), aph(3¢), ant(6), erm(B)
4 Blood AN 1 Sm, Gen, Amk, Chlo, Ery, Tet, Cip aac(6¢)–aph(2¢), aph(3¢), ant(6)
4 Blood AO 1 Gen, Amk, Ery aac(6¢)–aph(2¢)
7 Skin AP 1 Sm, Gen, Amk, Chlo, Ery, Tet aac(6¢)–aph(2¢), ant(6)
7 Levin tube AQ 1 Tet
7 Urine AR 1
7 Skin AS 1 Sm, Amk, Chlo, Ery, Tet aph(3¢), ant(6)
6 Blood AT 1 Ery, Tet
Enterococcus
faecium
Santiago de Cuba 2
2
CSF ⁄Urethra
Ear swab
UM-A
UM-B
2
1
Amp, Sm, Gen, Amk, Ery, Tet, Cip
Tet
aac(6¢)–aph(2¢), aph(3¢), ant(6), erm(B)
2 Catheter UM-C 1 Amp, Gen, Amk, Tet aac(6¢)–aph(2¢), aph(3¢)
Havana City 7 Endotracheal tube UM-D 1 Gen, Amk, Chlo, Tet, Cip aac(6¢)–aph(2¢)
4 Urine UM-E 1 Amp, Sm, Gen, Amk, Tet aac(6¢)–aph(2¢)
4 Urine UM-F 1 Tet
4 Blood UM-G 1 Amp, Van, Tei, Chlo, Ery, Tet vanA
7 Bladder drainage UM-H 1 Tet, Cip, Fos
7 Endotracheal tube UM-I 1 Cip, Fos
Enterococcus
casseliflavus
Santiago de Cuba 2
3
Wound
CSF
CAS-A
CAS-A
1
1
Amp, Gen, Amk, Tet, Cip
Ery, Cip
aac(6’)-aph(2’’)
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ant(6) gene was detected in 13 of 21 isolates with
streptomycin HLR, and the combination of ant(6)
and ant(3¢) genes was found in three isolates.
Another resistance mechanism may have been
present in five isolates with streptomycin HLR, as
no genetic determinants coding for enzymic
degradation were found.
The most frequent combinations of amino-
glycoside-modifying enzymes were aac(6¢)–
aph(2¢¢) + aph(3¢) + ant(6) in 11 isolates, followed
by aph(3¢) + ant(6) in six isolates, aac(6¢)–aph(2¢¢) +
aph(3¢) in five isolates, and aph(3¢) + ant(6) +
ant(3¢) in one isolate. Thirteen isolates carried
only the gene for the bifunctional enzyme,
whereas four different aminoglycoside-modifying
enzyme genes, namely aac(6¢)–aph(2¢¢) +
aph(3¢) + ant(6) + ant(3¢), were detected concur-
rently with the erm(B) gene in the E. faecalis L and
AG clones.
The results of the present study suggest that
certain E. faecalis clones are present in different
Cuban hospitals, although global genetic diversity
was observed concomitantly (1.7 isolates ⁄PFGE
pattern). Similar results from other countries have
found lower genetic diversity among isolates of
enterococci [20], suggesting that perhaps these
differences could be attributed to Cuban environ-
mental conditions (poor communications within
the country, sharing of the environment by
humans and animals, import of microorganisms
from overseas as a result of tourism, and strict
control of antimicrobial use in hospitals). Half of
the clinical isolates were resistant to three or more
antimicrobial agents, including aminoglycosides,
erythromycin, tetracycline, chloramphenicol and
ciprofloxacin. The resistance determinants identi-
fied in the study were very similar to those
reported from other countries. Although the
genetic relatedness and the antimicrobial resist-
ance of enterococci colonising the intestinal tract
of Cuban communities remain unknown, inter-
hospital circulation of particular clones, followed
by subsequent selection of these clones in the
hospital environment, appears to be the most
probable pattern of dissemination.
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ABSTRACT
This study investigated the prevalence of the
erm(A), erm(B) and erm(C) genes among 122 MLS-
resistant clinical isolates of Staphylococcus aureus
from a Turkish university hospital. Of these
isolates, 44 were inducibly resistant and 78 were
constitutively resistant. The presence of one or
more erm genes was demonstrated in 114 isolates;
the erm(C) gene was detected in 97 isolates, and
the erm(A) gene was detected in 96 isolates.
Seventy-eight isolates harboured both erm(A)
and erm(C). The combination of erm(A), erm(B)
and erm(C) genes was detected in only one isolate.
Keywords erm genes, lincosamide, macrolide, MLS
resistance, Staphylococcus aureus, streptogramin B
Original Submission: 2 May 2005; Revised Submis-
sion: 5 September 2005; Accepted: 21 December 2005
Clin Microbiol Infect 2006; 12: 797–799
10.1111/j.1469-0691.2006.01486.x
Macrolide (erythromycin), lincosamide (clinda-
mycin) and streptogramin B (vernamycin Ba)
antibiotics inhibit protein synthesis by binding
to overlapping sites in the 50S ribosomal sub-
unit [1]. Although they are chemically distinct
antibiotics, they have a similar mode of action.
Emergence of drug-resistant, especially methicil-
lin-resistant, Staphylococcus strains, has led to the
investigation of possible new antibiotics for the
treatment of staphylococcal infections. Use of
macrolide, lincosamide and streptogramin (MLS)
antibiotics is limited for staphylococcal infections,
but they are often considered as an alternative
treatment regiment [2,3].
Three different resistance mechanisms for
macrolide antibiotics have been described in sta-
phylococci, but the main mechanism involves
target-site modification following methylation of
the ribosome. The methylase enzyme adds one or
two methyl groups to the adenine residue in the 23S
rRNA moiety, and thereby decreases the affinity of
the ribosomal subunit for MLS antibiotics. Cross-
resistance to these chemically unrelated antibiotics
is observed since their binding sites overlap. The
second mechanism of resistance involves an efflux
system that results in resistance to macrolides and
streptogramin B antibiotics. The third mechanism
involves inactivation of antibiotics by the enzymes
acetyltransferase, hydrolase, nucleotidyltranferase
and phosphotransferase [4–6].
MLS resistance in staphylococci can be either
constitutively or inducibly expressed. While iso-
lates showing constitutive resistance are resistant
to 14-membered (erythromycin, roxithromycin,
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